Skip to main content

Table 3 Logrank and Cox cause-specific hazard ratios (csHR), subdistribution hazard ratios (subHR) and associated 95% confidence intervals for evaluating the treatment effect

From: Analysis and design of randomised clinical trials involving competing risks endpoints

  Unadjusted csHR Unadjusted subHR
Competing event Logrank Cox Subdistribution
M: Distant metastasis 0.43 (0.25 - 0.72) 0.43 (0.24 - 0.75) 0.43 (0.25 - 0.76)
R: Loco-regional recurrence 0.84 (0.34 - 2.07) 0.84 (0.34 - 2.08) 0.91 (0.37 - 2.24)